There are main two types of lung cancer: small cell lung cancer and non-small cell lung cancer. Lung cancer treatment depends on the stage of lung cancer, whether lung cancer has spread…
Category: Lung Cancer Treatment
Get to know about types of lung cancer treatment methods, causes, researches, early symptoms and stages. To know more details about the lung cancers browse the website.
Tagrisso Gets FDA Approval as Lung Cancer Drug
Lung cancer is one of the most deadly diseases among both men and women. A new drug has got FDA approval. AstraZeneca has got its approval for lung cancer drug Tagrisso. The…
Statins Do Not Improve Survival in Small Cell Lung Cancer
Statins are the cholesterol-lowering drugs. Do such drugs could be a part of cancer treatment as well? Such drugs works to lower cholesterol levels by blocking liver enzymes. It was thought that…
Drug: Tarceva (Erlotinib Hydrochloride) to Treat NSCLC
Tarceva (Erlotinib Hydrochloride) is a non-chemotherapy drug for the treatment of lung cancer. It is used in the treatment of recurrent NSCLC. It is approved for patients with advanced-stage NSCLC whose cancer…
Drug: Cyramza (Ramucirumab) to Treat NSCLC
Lung Cancer Treatment Cyramza (Ramucirumab) is an approved drug for the treatment of non-small cell lung cancer (NSCLC). It was approved by US FDA as a single agent for treatment of patients…
Drug: Crizotinib for Lung Cancer
Crizotinib FDA Approved Among cancer-related deaths in the United States, lung cancer is the leading cause. FDA has approved the use of Xalkori (crizotinib) for treating patients with non-small cell lung cancer…
Drug: Ceritinib to Treat NSCLC
Ceritinib for Lung Cancer Treatment Ceritinib is a drug for the treatment of lung cancer. It is the generic for the trade chemotherapy drug Zykadia. The drug is a prescription medicine to…
Drug: Avastin (Bevacizumab) to Treat NSCLC
Avastin for Lung Cancer Avastin (Bevacizumab) is a cancer medicine that works to stop the growth and spread of cancer cells. It is used to treat certain types of cancers such as…